News

July 2011

Lein recruits new mathematics intern
Following successful internships with Southampton and Reading Universities over the past two years, Lein is once again taking advantage of this valuable source of knowledgeable support and has engaged Sushmita Poudel to fulfill the role of mathematics intern.

Sushmita, who is a mathematician from the University of Reading, will be working on the processing of new clinical data being collected in Lein’s current clinical trial on volunteers with Type 1 diabetes.

May 2011

Lein is proud to announce we have moved to our new offices (www.lein-ad.com/contact.shtml).

Having outgrown our old offices we are delighted to have moved to the new state of the art building at the Reading Enterprise Centre (www.readingenterprisecentre.com/#/home).  The move is a sign of our continued development and growth with the new facilities providing larger offices, enhanced infrastructure, dedicated laboratories and our own testing room for clinical work.

The Reading Enterprise Centre, based on the University of Reading campus, brings together a community of innovation-led and technology-based businesses and places Lein closer to a number of its academic partners.

January 2011

Lein welcomes Rob Wilson, MP for Reading East

Lein were delighted to welcome Rob Wilson, MP for Reading East, to their offices in Reading on Friday 21st January. Rob was joined by Ivan Griffin, Madeleine Hallward, and Guy Bilgorri from the National Endowment for Science, Technology and the Arts (NESTA). NESTA, who alongside Seven Spires Investments and the UMIP Premier Fund, support Lein in its medical device development programme, are the UK's foremost independent experts on how innovation can solve the country's economic and social challenges. 

Whilst taking a tour of the Lein laboratories, Rob Wilson commented: “Diabetes is a growing problem around the world. Lein’s research has great potential to both improve the quality of life for people with diabetes and reduce this condition’s ever increasing financial burden on the healthcare system. It is very exciting that this innovative technology is being developed in the heart of Reading, and I look forward to watching the company grow.”

Dr Dan Daly, director and co- founder of Lein, remarked “with Rob Wilson’s experience as an entrepreneur, we know that he understands the challenges facing growing businesses. We have ambitious targets for our technology to stake a claim in the market for blood glucose monitoring, which is estimated to be worth over $10bn.”

October 2010

Lein exhibits at Innovate 10

Lein exhibited at the Technology Strategy Board’s Innovate 10 exhibition in London this October. The exhibition was a great success with our stand welcoming many visitors from all sectors of the UK’s technology-based industries. The highlight was a demonstration of our high resolution metrology device measuring contact lenses.

 

June 2010

Lein receives ECIF support for 2 internships

Lein is delighted to announce that it has received support for two internships from the Economic Challenge Investment Fund (ECIF).

 

Filipe Santos, whose background is in Biomedical Engineering, will be working at Lein’s Reading offices on the planning and implementation of the next series of glucose clinical trials.

 

 

 

Vikram Mehta will be working at the Department of Optometry and Visual Science, City University, London with Professor John Lawrenson. His work will investigate the detailed changes to ex-vivo eyes in response to fluctuating glucose levels.

 

March 2010

Lein launches new website

Lein Applied Diagnostics is very proud to announce the launch of their redesigned website. Wokingham Web Works and Mayhem 14 were engaged to redesign the existing Lein website, incorporating the company's new branding, as well as implementing new and improved information architecture and interface design. A user-friendly navigational tool bar allows users to view the contents of the site and quickly locate the information they need, enabling them to stay current with news and developments.

December 2009

Lein closes second and final half of funding round

Lein is delighted to announce that it has closed the second and final tranche of its current funding round. This additional investment complements the funding received in October from UPF (the UMIP Premier Fund, managed by MTI) and the National Endowment for Science, Technology and the Arts (NESTA).

The investors in this second tranche consist of a syndicate of very experienced business angels. “Our angel investors bring a lot more to Lein than just their investment” explained Dan Daly, Director. “Together they have very broad business, commercial and financial experience along with expertise in medical devices and the more general healthcare market. This expertise will prove extremely beneficial to Lein over the long term”.

This additional funding will enable Lein to increase the scale of its next stage clinical trials, address new applications and push forwards more rapidly with the miniaturisation of its technology.

November 2009

Industrial Maths Internship successfully completed

Shayan Motamedi Fakhr, a Ph.D. student in the School of Engineering Sciences at the University of Southampton, successfully completed his Industrial Mathematics Internship with Lein in November. The internship, facilitated by the Industrial Mathematics Knowledge Transfer Network, enables students to gain firsthand experience of working in industry. Shayan’s signal processing expertise and enthusiasm brought new insights to Lein’s work in data analysis.

October 2009

Lein secures £1 million funding from UPF and NESTA

Lein, developer of non-invasive optical measurement technology, announces that it has raised £1 million from the UPF (the UMIP Premier Fund, managed by MTI) and the National Endowment for Science, Technology and the Arts (NESTA).

The new investment in Lein is to enable the company to miniaturise its pain-free medical diagnostics technology so that in its next generation of clinical trials, the technology will be in the form of convenient, hand-held devices.

Alongside these technical advances Lein intends to undertake further clinical work on blood glucose monitoring, building on studies already undertaken at The Royal Berkshire Hospital.

Having closed this institutional section of the investment round Lein has allowed a window of 30 days for a number of business angel investors to invest alongside UPF and NESTA.

Read the full Press Release          

October 2009

Lein Engineer receives a Highly Commended British Engineering Excellence Award

Lein is delighted to announce that Dr Robin Taylor, Senior Engineer at Lein, received a commendation at this year's prestigious British Engineering Excellence Awards in the Design Engineer of the Year category.

The Awards aim to celebrate UK engineering excellence and promote quality engineering design and innovation. The winners were announced at the award ceremony at London's Globe Theatre on the 1st October 2009.

For this award, sponsored by element14, nominees had to have demonstrated the ability to produce innovative designs with transferable technology within strict commercial limits. The judges felt that the competition in this category was so strong that it was necessary to award a Highly Commended to Robin for his role in developing Lein's core technology.

June 2009

Lein exhibits at Innovation EXPO 2009

Lein was invited by the National Innovation Centre of the NHS to exhibit at the Innovation Expo at the Excel Centre on the 18th and 19th June 2009.

Lein exhibited its platform optical technology with particular emphasis on its non-invasive glucose meter.

The purpose of the Innovation EXPO was to accelerate the adoption and diffusion of innovation throughout the NHS. It was aimed at a broad audience interested in innovation in healthcare with a wide range of speakers, exhibits and seminars.

May 2009

Lein collaborates with Durham University on Pharmacokinetics

Lein has signed a contract with the Biophotonics Instrumentation Group at Durham University to sponsor a three-year PhD studentship under the EPSRC CASE award scheme. The project is to be managed by Professor John Girkin, who has extensive experience applying confocal measurements to biological systems. He will be supported by Professor Clive Wilson's research group at Strathclyde University, who have expertise in clinical imaging, drug delivery and pharmacokinetics.

The goal of the collaboration is to adapt Lein’s confocal technology and to apply it to the non-invasive measurement of the level of, and the diffusion characteristics of, pharmaceutical drugs in the body via the eye.

March 2009

Lein to receive further support from the National Innovation Centre

Last year Lein received support from the NHS National Innovation Centre (NIC) to undertake a small clinical trial at the Royal Berkshire Hospital RBH on its non-invasive glucose meter prototype and to miniaturise its scanning technology.

Following the successful completion of these initial projects the NIC has provided Lein and the RBH with further support to:

• develop a miniature demonstrator of Lein’s technology;
• undertake further clinical work to demonstrate the efficacy and specificity of Lein’s meter.

The role of the NIC is to speed up the development of pre-commercial technologies likely to benefit the NHS. More information about their work can be found at www.nic.nhs.uk.

January 2009

Lein files seventh patent

Lein filed the seventh in its suite of patents to protect its innovative technology for making non-invasive measurements of the body via the eye. This new patent protects Lein’s method of accurately tracking the measurement beam within the eye.

“Accurate knowledge of the position of the measurement beam is key to Lein’s measurement process. This latest patent adds to our proprietary knowledge in this area and has many exciting applications in both the health care and industrial sectors” said Robin Taylor.